COMP <GO>
ARGX vs GILD // NET PROFIT MARGIN
argenx SE (NASDAQ) VS. Gilead Sciences Inc. (NASDAQ) • 15-METRIC TALLY: ARGX 2
— GILD 9
▲ NET PROFIT MARGIN LEADER: GILD
LAST: $892.87 (-0.56%) • MKT CAP: $55.72B
net-margins
10.90%
LAST: $170.68 (+3.06%) • MKT CAP: $205.35B
net-margins
28.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ARGX VS. GILD)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ARGX | GILD | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 78.80% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.90% | 21.00% | -11.10 | GILD | /roic <GO> |
| EV/EBITDA & P/E Valuation | 21.0x | 21.0x | 0.00 | TIE | /valuation <GO> |
| Free Cash Flow Yield | 2.21% | 4.60% | -2.39 | GILD | /fcf-yield <GO> |
| Operating Margin | 13.90% | 34.00% | -20.10 | GILD | /operating-margins <GO> |
| Net Profit Margin ACTIVE | 10.90% | 28.90% | -18.00 | GILD | /net-margins <GO> |
| Revenue Growth (YoY) | 18.70% | 2.40% | +16.30 | ARGX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.95% | -1.95 | GILD | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 3.74 | 5.87 | -2.13 | GILD | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 8/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 51.7 | 64.3 | -12.60 | GILD | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.02 | 0.88 | +0.14 | ARGX | /macro-sensitivity <GO> |
| Forward P/E Multiple | 27.6x | 22.4x | +5.20 | GILD | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $55.72B | $205.35B | -$149.63B | GILD | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ARGX REV | GILD REV | ARGX GROSS % | GILD GROSS % | ARGX FCF | GILD FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $29.44B | — | 78.8% | — | $9.46B |
| FY 2024 | — | $28.75B | — | 78.3% | — | $10.30B |
| FY 2023 | — | $27.12B | — | — | — | $6.79B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ARGX // BETA 1.02
GILD // BETA 0.88